A proinflammatory marker in chronic rhinosinusitis: serum calprotectin

dc.contributor.authorÇandar, Tuba
dc.contributor.authorBaklacı, Deniz
dc.contributor.authorKuzucu, İhsan
dc.contributor.authorKayabaşı, Serkan
dc.date.accessioned2021-06-07T09:52:23Z
dc.date.available2021-06-07T09:52:23Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.description*Kayabaşı, Serkan ( Aksaray, Yazar )
dc.description.abstractIntroduction: Studies have shown that calprotectin has a strong pro-inflammatory effect. Elevated calprotectin levels in the serum can be used as a strong clinical marker indicating the presence of inflammation. Objective: To investigate serum calprotectin levels in patients with chronic rhinosinusitis (CRS) and to determine the applicability of calprotectin as a potential molecular proinflammatory biomarker for CRS. Methods: The study consisted of three groups: chronic rhinosinusitis with polyps (CRSwNP group), chronic rhinosinusitis without polyps (CRSwoNP), and healthy control. CRS patients with polyps were further divided into two groups depending on the presence/absence of Samter’s triad. The Nose Obstruction Symptom Evaluation (NOSE) scale score and serum calprotectin value were evaluated in all participants. Results: The mean serum calprotectin value was 79.5±11.8 ng/ml for the CRSwNP group, 71.3±16 ng/ ml for the CRSwoNP group, and 61.9±11.6 ng/ml for the control group (p<0.001). The Samter’s triad group had a significantly higher calprotectin value than the non- Samter’s triad group (p=0.03). There was a significant correlation between the NOSE scores and calprotectin levels (rho=0.734, p<0.001). Conclusion: Serum calprotectin values were correlated with the severity of symptoms in patients with CRS; thus, it seems to be a valuable pro-inflammatory biomarker for the diagnosis of the disease and determining its severity. Further studies with larger series are needed to evaluate the preoperative and postoperative serum calprotectin values in patients undergoing surgery.
dc.identifier.doi10.18388/abp.2020_5204
dc.identifier.endpage371en_US
dc.identifier.issue3en_US
dc.identifier.pmid32865947
dc.identifier.scopusqualityQ3
dc.identifier.startpage367en_US
dc.identifier.urihttps:/dx.doi.org/10.18388/abp.2020_5204
dc.identifier.urihttps://hdl.handle.net/20.500.12451/8073
dc.identifier.volume67en_US
dc.identifier.wosWOS:000572533100014
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherActa Biochimica Polonica
dc.relation.ispartofActa Biochimica Polonica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectCalprotectin
dc.subjectChronic Rhinosinusitis
dc.subjectNasal Polyp
dc.titleA proinflammatory marker in chronic rhinosinusitis: serum calprotectin
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
candar-tuba-2020.pdf
Boyut:
328.56 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: